The next-generation cardiac monitor, which is 60% smaller than its predecessor, is intended to provide information on suspected arrhythmia or unexplained syncope with increased clarity.
It is expected to allow quick diagnosis and appropriate treatment and is available pre-loaded in an injection tool.
To simplify the insertion process, BIOMONITOR III does not require assembly. The single-piece injection design is meant for easy usage in different clinical settings, including office-based procedures.
